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Abstract
Background: Elevated serum-free fatty acid (FFA) levels induce insulin resistance (IR) or a protective 
mechanism to IR development in humans; it depends on FFA type. Objetive: This study explores the effects of 
oleic (OLA – unsatured) and palmitic (PAM – saturated) fatty acids on insulin action in mature adipocytes effect. 
Methods: Cells were incubated 18 h with or without OLA and PAM at 250 μM, and 500 μM. After the culture 
period, were measured: adipocyte viability, size, fatty acids mobilisation, insulin signalling proteins, and glucose 
uptake. Results: Adipocytes exhibited optimal viability tolerances regardless of the kinds of fatty acids used for 
treatment. However, adipocytes were hypertrophic after OLA and PAM stimuli. Additionally, lipogenesis (lipid 
synthesis), and lipolysis (lipid breakdown) were significantly increased by treatment with OLA, or PAM (500 μM) 
compared to control. Moreover, OLA results showed that there was no significant reduction in signalling cascades, 
except for a downstream proinflammatory response. Instead, PAM hypertrophic adipocytes were insulin resistant 
with alteration of proinflammatory and stress markers. Conclusions: Current findings suggest that PAM induces 
insulin resistance, mitochondrial and reticulum stress on fat cells compared to those treated with OLA that, protects 
adipocytes to all those alterations.
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Resumen
Introducción: los niveles elevados de ácidos grasos libres (AGL) en suero inducen resistencia a insulina (RI) 
o un mecanismo de protección del desarrollo de RI en humanos, esto depende del tipo de AGL. Objetivo: este 
estudio explora los efectos de los ácidos grasos oleico (insaturados – OLA) y palmítico (saturados – PAM) sobre 
la insulina en adipocitos maduros. Métodos: las células se incubaron 18 h con o sin OLA y PAM a 250 μM y 
500 μM. Después del período de cultivo, se evaluó en adipocitos: viabilidad, tamaño, movilización de ácidos grasos, 
proteínas de señalización de insulina y absorción de glucosa. Resultados: los adipocitos mostraron viabilidad óptima 
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independientemente de los tipos de ácidos grasos utilizados en el tratamiento. Los adipocitos eran hipertróficos tras 
estimulo con OLA y PAM. La lipogénesis (síntesis de lípidos) y la lipólisis (degradación de lípidos) aumentaron 
significativamente con el tratamiento con OLA o PAM (500 μM) en comparación con el control. En los resultados 
de OLA no se evidenció una reducción significativa en las cascadas de señalización de insulina, a excepción de una 
respuesta proinflamatoria posterior. En cambio, los adipocitos hipertróficos tratados con PAM presentaron resistencia 
a la insulina y alteración de los marcadores proinflamatorios y de estrés. Conclusiones: nuestros hallazgos sugieren 
que PAM induce resistencia a la insulina, estrés mitocondrial y del retículo en las células grasas en comparación con 
aquellos tratados con OLA, AGL que, en cambio, protegen a los adipocitos de todas esas alteraciones.
Palabras clave: Adipocito; Ácidos Grasos; Ácido Oleico; Ácido Palmítico; Resistencia a la Insulina; Insulina; 
Lipolisis; Lipogénesis. 
Introduction
Obesity is associated with different metabolic disorders 
that often lead to insulin resistance (IR). Obesity is a 
pathological mechanism and major metabolic disorder 
developed by a problem in insulin receptor signaling in 
insulin target tissues such as adipose tissue, pancreas, 
among others1,2. However, IR abnormalities are rarely 
in all obese people3,4, there is an obesity phenotype 
of obese subjects called metabolically healthy obese 
(MHO), in contrast to the other obese phenotype, IR 
individuals, this group of patients shows a favourable 
metabolic profile, defined by high levels of insulin 
sensitivity, low prevalence of hypertension, and a 
helpful lipid and inflammation profile5,6.  Nevertheless, 
the increase of adipose tissue in both obese conditions 
reflected an increase in levels of circulating free fatty 
acids (FFA). The levels of plasma free fatty acids are 
released by adipose tissue, and they reflect food intake: 
oleic acid (OLA, 18 : 1) and palmitic acid (PAM, 16: 0) 
are the most abundant in diet and plasma7.
According to these, cells models have been widely 
used to study metabolic health obese (MHO) and 
insulin-resistant (IR) in adipocytes phenotype called, 
metabolically unhealthy obese (MUHO), to simulate 
both physiological states. Several agents might be used 
to mimic obese conditions: TNFα8, IL-19, high insulin 
and high glucose10, hypoxia11, among others12,13.
Free unsaturated fatty acid like oleic acid (OLA) 
and linoleate as well as saturated fatty acids such as 
myristate, palmitic acid (PAM) and stearate, play the 
central role as obese adipocyte models due to their 
features associated with their chemical structure14.  The 
saturated fatty acids are linked to IR inducing a cellular 
stress response related to the endoplasmic reticulum, 
and a chronic inflammatory state by the altered 
pattern of adipokines in the adipose tissue15. However, 
monounsaturated fatty acids might be involved as a 
protective mechanism for IR, consequently of their 
chemical structure by being capable of altering the 
fluidity of the cell membrane, modulate the regulation 
of transcription factors and the expression of some 
genes related to energetic metabolism16. In this context, 
this work aims to visualise the response of cultured 
adipocytes to palmitic acid and oleic acid treatment, 
how these fatty acids also respond to insulin and try to 
simulate  obese phenotypes. 
Material and Methods
Cell culture
3T3-L1 [obtained from the American Type Culture 
Collection (Manassas, VA)] were differentiate into 
adipocytes, as previously described17. Briefly we seeded 
at 2x105 cell/cm2 and growth in adipocyte medium 
[DMEM/F-12 [1:1] (Invitrogen), 17.5 mmol/l glucose, 
4 mmol/l L-glutamine, 1% antibiotic-antimycotic 
(v/v), 1.5 g/l sodium bicarbonate] supplemented with 
10% of fetal bovine serum (FBS, Gibco). After 4 
days, the medium was changed to adipocyte medium 
supplemented with 3% FBS, 0.5 mmol/l 3-isobutyl-
1-methylxanthine (IBMX, Sigma), 0.1 mmol/l 
dexamethasone (Sigma), and 10 µg/ml insulin (Sigma). 
After 3-days induction period, cells were fed every two 
days with the same medium, but without IBMX for 
the remaining eight days of adipocyte differentiation17. 
Media was exchanged for DMEM without insulin until 
day ten when all the experiments were carried out.
 
In vitro Models induction
Differentiated adipocytes were serum-starved for two 
hours and then treated with OLA (Sigma) (250 µmol/l, 
and 500 µmol/l) as previously described18, or PAM 
(Sigma) (250 µmol/l, and 500 µmol/l)19,20 with some 
protocol modifications, complexed to BSA at a 2:1 ratio 
for 18 hours. One sample per experiment was used to 
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obtain control responses in the presence of the solvent. 
After model induction with fatty acids, the cell models 
and controls were treated with insulin 100 nmol/l for 5 
minutes to evaluate insulin response.
Oil Red O staining
Cells treated with fatty acids (OLA or PAM) were 
stained with Oil Red O to measure the diameter 
by optical microscopy. Briefly, cells were fixed in 
paraformaldehyde 4% (m/v) at room temperature in 
Phosphate Buffered Saline [PBS 0.01 mmol/l, pH 
7.4] for 15 minutes, washed with isopropanol (Sigma) 
60% (v/v), and stained with Oil Red O (Sigma) for 30 
minutes. Cells were visualised by Optic Microscopy 
Leica DM500 (Leica). 
MTT assay
Cell viability was determined by MTT 
(3-(4.5-Dimethylthiazol-2-yl)-2.5-diphenyltetrazolium 
bromide, Sigma) assay. After model induction with 
OLA or PAM in 3T3-L1 adipocytes, cell models and 
controls were incubated with 0.5 g/L of MTT solution 
by 5 hours at 37°C and washed out with PBS and 
Dimethyl sulfoxide (DMSO, Sigma). Absorbance was 
recorded at 570 nm. 
Lipolysis (Lipid Breakdown) and 
Lipogenesis (Lipid Synthesis)
Cellular lipolysis and lipogenesis were measured using 
enzymatic methods. Specifically, for lipogenesis, cells 
were homogenised in lysis RIPA buffer (0.1% SDS, 1% 
Triton-X-100, 5 mM EDTA, 1 mM Tris HCl, 150 mM 
NaCl and 1% deoxycholate; pH 7.4), and intracellular 
triglycerides were quantified by Triglycerides Liquid 
Stable Reagent kit (Sigma). Triglyceride levels were 
normalised to total protein content. 
Lipolysis was also quantified in 3T3-L1 adipocyte cells 
models induction. Extracellular glycerol was measured 
by using a Free Glycerol Reagent kit (Sigma). In 
this case, intracellular protein content was used for 
normalisation. Intra- and inter-assay coefficients of 
variation were 3.3 and 4.2%, respectively. All assays 
were carried out in triplicate.
Immunoblotting
Cells were disrupted and homogenised with Triton 
buffer (20 mm Tris pH 7.4, 150 mm NaCl, 1% Triton, 
and complete protease inhibitor) and incubated in the 
presence of 30 units of DNase I (Sigma) for 15 min 
on ice. Protein content was quantified by the Bradford 
method using bovine serum albumin (Sigma) as 
standard as described before17. Equal amounts of 
protein (30 μg) were separated by 10% of sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) under denaturing conditions, transferred 
to nitrocellulose membranes (Bio-Rad), and blocked 
in Tris-buffer saline with 0.05% Tween-20 (TBS-T) 
containing 5% dried milk for 1 h at room temperature17. 
Subsequently, blots were incubated overnight at 4°C 
with primary antibodies against Protein kinase B 
(Akt, Cell signalling), phospho (Thr308)-Akt (pAkt, 
Cell signalling), c-Jun N-terminal kinases (JNK, RD 
Systems), phospho (Thr183 and Thr185)-JNK (pJNK, 
Santa Cruz), Insulin receptor substrate 1 (IRS-1, Santa 
Cruz), phospho (Tyr 612) IRS-1 (pIR, Cell signalling), 
C/EBP homologous protein (CHOP, Santa Cruz), 
glutathione synthetase (GSS, Abcam), and β-actin 
(Sigma). Primary antibody was removed; subsequently, 
the membrane was incubated with secondary antibody. 
The antigen-antibody complexes were visualised 
using horseradish peroxidase-conjugated anti-rabbit, 
anti-mouse, or anti-goat IgG antibodies (Abcam), 
the enhanced chemiluminescence kit (ECL-Pls, Ge 
Healthcare), and autoradiography films (Sigma)17. Band 
intensity determined by densitometric analysis with the 
Gel DocTM gel documentation system-Quantity One 
4.5.0 software (Bio-Rad) and normalised with β-actin 
density values. 
Glucose Concentration by Glucose Oxidase 
Assay
The glucose oxidase assay was performed by using the 
Glucose Assay Kit (Sigma). The medium from 3T3-
L1 adipocytes with or without model induction was 
removed, and its glucose concentration was determined 
as described before18. The absorbance was measured at 
540 nm using a UV spectrophotometer. All assays were 
carried out in triplicate.
Statistical analysis 
Data are expressed as the mean ± SEM. Statistical 
differences between mean values were analysed one-
way ANOVA with a multiple post-hoc-Newman Keuls. 
Comparison of two variants was made with the student´s 
t-test. P-value < 0.05 was considered statistically 
significant. At least three repetitions of each experiment 
were used. The statistical analyses were performed 
using the SPSS/Windows version 15.0 software (SPSS 
Inc. Chicago, IL, USA).
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Results
Exposure to unsaturated and saturated fatty acids has 
been associated with a protective effect or insulin-
resistant development. Therefore, we evaluated OLA 
and PAM model induction on mature adipocytes and 
their impact on adipocyte size, fatty acids mobilisation, 
insulin pathways responsiveness, and glucose uptake.
OLA and PAM treatments effect on viability 
and cell diameter of mature adipocytes. 
To evaluate the effect on cell viability of adipocytes 
exposed to OLA and PAM as exhibit the Figure 1a and 
1b, respectively, we perform the MTT assay based on the 
activity of mitochondrial dehydrogenases. Specifically, 
the 250 uM OLA and PAM concentration resulted in 
the maximum cell growth with 107.9% and 97.7% of 
viability, respectively, after applying stimuli for 18 
hours. When the doses were increased to 500 uM of 
OLA or PAM stimuli, the viability of the cell decreased 
slightly. However, viability reductions respect to the 
control were not representative at both concentrations 
after OLA, and PAM treatment. In the present study, both 
concentrations 250 uM and 500 uM of OLA, or PAM 
have high viability, as exhibit the Figure 1. Therefore, 
adipocytes exhibited optimal viability tolerances 
regardless of the kinds of fatty acids used for treatment. 
Moreover, to characterise adipocytes hypertrophic, cell 
diameter was measured in adipocytes exposed to OLA, 
or PAM as show the Figure 1c and 1d, respectively, 
which increased progressively with the concentration 
administered. However, the cell diameter was higher 
in those that were treated with 500 μM OLA compared 
to OLA 250 uM, control cells, and those treated with 
both PAM concentrations. In line with these results, the 
microscopy representative cells stained with Oil Red 
O after OLA as exhibit the Figure 1e, or PAM in the 
Figure 1f, which confirm the presence of hypertrophic 
adipocytes after OLA and PAM stimuli.
Figure 1. Effect of Oleate and Palmitate treatment on 3T3-L1 adipocytes. Cell viability graphs after (a) OLA, or (b) PAM 
250 µM, and 500 µM treatment on adipocytes. Cell diameter graphs after (c) OLA, or (d) PAM at different concentrations. Cells 
morphology with oil red O staining after (e) OLA, or (f) PAM treatment. Data are represented as % cell viability vs control 
(100%).  Bar graphs represent control cells (white), 250 µM (grey) and 500 µM (black). Values are the mean ± SEM. Differences 
between groups were analysed by one-way ANOVA followed by Scheffe test; ***P<0.001 vs Control; ## p < 0.01 vs 250 µM 
OLA concentration.
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OLA and PAM treatments effect on 
adipocytes fatty acids mobilisation 
To determine OLA or PAM effect on adipocytes fatty 
acids mobilisation, triglycerides amount in cell lysates 
and the glycerol content after OLA as demonstrate 
the Figure 2a and 2b, respectively, or PAM as exhibit 
the Figure 2c and 2d, respectively were measured. 
Both triglycerides accumulation and glycerol content 
were significantly increased by treatment with OLA, 
or PAM (500 μM) compared to control. Furthermore, 
triglycerides content was higher after OLA at lower 
concentrations (250 μM) respect to the control.
Figure 2. Fatty acids mobilisation. Intracellular triglyceride content (lipogenesis) and glycerol release (Lipolysis) graphs after 
OLA (a, b respectively), and PAM (c, d respectively) treatment. Data are presented as % cell viability vs control (100%).  Bar 
graphs represent control cells (white), 250 µM (grey), and 500 µM (black) OLA, or PAM concentrations. Values are the mean 
± SEM. Differences between groups were analysed by one-way ANOVA followed by Scheffe test; *P < 0.05; **P < 0.01; and 
***P < 0.001 vs Control; ###p < 0.001 vs 250 µM OLA concentration.
Insulin pathways responsiveness of mature 
adipocytes to Oleate and Palmitate stimuli
To assess insulin sensitivity of hypertrophic models, 
we performed AKT activity measuring pAKT/AKT 
ratio of mature adipocytes exposed to OLA or PAM as 
exhibit the Figure 3a and 3b at different concentrations 
(250 uM and 500 uM), and insulin stimuli (100 nM). 
OLA at both concentrations do not had any significant 
(p > 0.05) differences respect to control cells; however, 
PAM treatment showed a considerable pAkt/Akt ratio 
reduction respect to the control (p < 0.05). Considering 
the changes obtained with OLA, or PAM at 500 uM 
concentration, the subsequent assays were performed at 
this dose. 
Unexpectedly, in OLA-induced hypertrophic 
adipocytes, the downstream insulin signalling pathway, 
tyrosine IRS-1 (IRs), tyrosine phosphorylation IRS-1 
(pIRs), oxidative (glutathione synthetase (GSH)), and 
reticulum (transcription factor C/EBP homologous 
protein (CHOP)) stress markers were not different from 
control cells, in contrast with the pro-inflammatory 
protein kinase Jun N-terminal (JNK) which decreased 
respect to the control as demonstrate the Figure 
3c. Besides, PAM stimuli signalling pathways were 
modified, specifically, reduced IRs level expression to 
control, while pIRs, GSH, CHOP, and JNK markers 
were increased significantly respect to control cells as 
exhibit the Figure 3d. Therefore, OLA results showed 
that there was no significant reduction in signalling 
cascades as demonstrate the Figure 3c, except for a 
downstream in the proinflammatory response. Instead, 
PAM hypertrophic adipocytes were insulin resistant 
with alteration of upstream signalling cascades.
Oleate and Palmitate treatment effect on 
glucose uptake of adipocyte
To assess insulin sensitivity of hypertrophic adipocyte 
models, we performed insulin-dependent glucose 
uptake assays. As shown in Figure 4, insulin-dependent 
glucose uptake was attenuated in OLA hypertrophic 
adipocytes. Nevertheless, PAM induces only minor 
impairment of insulin-stimulation of glucose uptake. 
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Figure 3. Effects of OLA and PAM models on 3T3-L1 adipocytes insulin signalling pathway. Insulin response (pAkt/Akt ratios) 
of 3T3-L1 cells exposed to (a) OLA, or (b) PAM at different concentrations (250 µM-gray bars and 500 µM-black bars). After 
treatments, control and treated cells were stimulated with insulin (100 nM) during 5 min. Cell lysates were analysed for Akt 
and pAkt content. Representative immunoblots of GSH, IRs, pIRs, JNK, pJNK (left panel), and quantification of protein levels 
(right panel) in 3T3-L1 adipocytes cultured for 18 h in the absence (Control) or presence of (c) OLA, or (d) PAM. Data were 
normalised to β-Actin. Data are expressed as a percentage of the values respect to the control (100%). Values are the mean ± 
SEM. Differences between groups were analysed by one-way ANOVA followed by Scheffe test; *P < 0.05.
Figure 4. Glucose uptake of adipocytes exposed to OLA, or 
PAM. The effect of 500 µM OLA, or PAM induction cells 
model on glucose oxidase assay. Bar graphs show glucose 
levels in OLA, or PAM/insulin presence (+), or absence 
(-) of six observations, expressed as glucose concentration 
(mg/ml). Values are the mean ± SEM. Differences between 
groups were analysed by one-way ANOVA followed by 
Scheffe test; *P < 0.05; **P < 0.01;  ***P < 0.001 vs Control.
Discussion
The IR, defined as a deficiency in the ability of this 
hormone to direct glucose into the cells and to direct 
its metabolism, is a metabolic state that precedes and 
predisposes to the development of type II diabetes. This 
condition eventually ends in hyperglycaemia when the 
pancreatic beta cells do not secrete enough insulin to 
cover the growing metabolic needs of this hormone. 
The increase of adipose tissue in obese patients is 
reflected in an increase in levels of circulating FFA, 
proinflammatory cytokines and other factors associated 
with IR. The plasma levels of acyl-glycerides released 
by the adipose tissue are a fair reflection of their dietary 
intake: OLA and PAM are the most abundant in the diet 
and plasma. This work aims to study the response of 
cultured adipocytes to treatment with OLA and PAM, 
and how these fatty acids affect the insulin response.
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Herein, we demonstrate that OLA and PAM treatment 
stimulates in adipocytes both, hypertrophy as well as 
triglycerides content. Previous studies have shown the 
ability of adipocytes to produce growth factors and 
cytokines with the capacity to induce the proliferation 
and adipocytes hypertrophy. However, the adipocytes 
treatment with OLA and PAM seems to alter the pattern 
of cytokines, causing changes in the cell effect of 
the high content of OLA and PAM17,21,22, mainly, as a 
response to the metabolic changes that cause the lipid 
overload in the adipocytes after both treatments. 
Together with the increase in cell proliferation and 
hypertrophy, it became evident how the treatment 
with PAM and OLA encouraged the synthesis of 
neutral lipids. Our work shows how OLA stimulates 
to a greater extent, the deposit of triglycerides in 
the adipocyte compared to PAM. Previous studies 
performed skeletal muscle has allowed showing that 
the excess of unsaturated fatty acids promote mainly 
the storage of triglycerides, while saturated fatty acids 
tend to be deposited in the form of diacylglycerides 
and ceramides23,24. It has also been shown that the cup 
of lipolysis decreases in these cells treated with PAM 
compared with those treated with OLA, suggesting an 
adaptive modification of the lipogenic profile on fat 
cells. All these studies carried out in different types of 
cells could explain our findings in mature adipocytes.
Additionally, our assays demonstrate for the first time 
that adipocytes treated with PAM increase the pIRS 
and pJNK levels compared to OLA treated cells. This 
suggests that PAM treatment induces in adipocytes 
mechanisms that could lead to IR, in this context, 
previous studies have shown how the increase of 
diacylglycerides in muscle cells, treated with PAM, 
activate the isoform of protein kinase C (PKCθ), which 
can phosphorylate JNK, activating a signalling cascade 
that induces the expression of proinflammatory genes25. 
Furthermore, our results showed an increase in pJNK, 
greater levels in cells treated with PAM compared to 
those treated with OLA, a finding suggestive of a 
similar mechanism. The pJNK increase can lead to the 
activation of subunit B of the kinase Ikβ (lKKβ) that 
would induce the phosphorylation of serine residues 
in the insulin response substrate IRS1, explaining the 
increase in pIRS, found in our work and the ability to 
induce IR in adipocytes treated with PAM compared to 
those treated with OLA23.
On the other hand, an interesting finding is the increase 
of glutathione synthetase (GSH) levels in PAM treated 
cells, which could show an increase of oxidative 
stress in those cells. The rise of FFA and ceramides 
reduces the oxidative capacity of the mitochondria by 
increasing free FFA levels and triggering incomplete 
oxidation of fatty acids, producing reactive oxygen 
species linked to mitochondrial stress that could lead 
to cell damage and IR26,27.
The OLA treated adipocytes showed lower CHOP 
levels than those treated with PAM. It is important to 
remember that PAM treatment leads to an increase in 
ceramides that could be responsible for endoplasmic 
reticulum stress, which is evident with the rise of CHOP 
protein in cells treated with PAM. A mechanism that 
could explain this could be the activation of several pro-
inflammatory pathways such as Jun N-terminal kinase 
(JNK), as demonstrate our work. However, routes such 
as NF-κB or similar receptors NOD containing residues 
of purine (NLRP3) could also be involved28. All these 
variations are evident in our work when we compare 
levels of proinflammatory molecular markers in cells 
exposed to OLA and PAM. We can see how the PAM 
substantially modifies the expression of these markers 
which results in a reduced response to insulin and an 
increase of pro-inflammatory markers, which is like 
to adipocyte MUHO phenotype5,6,19,29, this effect is 
not evident when cells were treated with OLA which 
is similar at least in part to the MHO adipocytes 
phenotype5,6,19,29.
Interestingly, the adipocytes treatment with PAM 
increases the entry of glucose into the cell compared to 
the control. That result suggests that the mechanism of 
admission must be independent of the action of insulin 
if we consider the previous findings of this work. A 
possible mechanism could be through the epidermal 
growth factor (EGF) a cytokine produced by adipocytes 
that induce glucose transport. Despite several findings 
suggesting OLA with less capacity make insulin 
resistance than PAM, our results showed that the cells 
treated with PAM had better glucose transport capacity 
than those treated with OLA, under our conditions, 
which could corroborate that an insulin-independent 
mechanism could be activated that enhances glucose 
entry in cells treated with PAM20,30.
Conclusions
In conclusion, our work suggest that PAM treatment 
induces insulin resistance, mitochondrial stress and 
reticulum stress on fat cells which is like MUHO 
adipocytes phenotype, compared to those treated with 
OLA, which seems similar, at least in part to MHO 
adipocyte phenotype, however, treatment with PAM 
may induces glucose transport in adipocytes by a 
different route from insulin-dependent.
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